Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Phillip McGaha

Pediatrics Charleston, SC Medical Doctor

NPI 1295786556 CMS profile 240581

1871 Savage Road, Charleston, SC 29407

Open in the dashboard

General payments

$2,393

132 records reported · program years 2019–2025

Research payments

$2,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$290,382 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Phillip McGaha of Charleston, SC is reported in the CMS Open Payments database as having received $2,393 across 132 general payments and $2,500 in research payments paid to them. Separately, studies naming them as principal investigator received $290,382 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $261 11
2024 General $544 25
2023 General $292 17
2023 Research $2,500 1
2022 General $215 12
2021 General $433 23
2020 General $279 18
2019 General $369 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Phillip McGaha
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Phillip McGaha were reported at $261. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Phillip McGaha Pediatrics median Middle half National median
2019 $369 $86 $31–$183 $163
2020 $279 $49 $22–$110 $114
2021 $433 $68 $27–$158 $132
2022 $215 $77 $30–$173 $149
2023 $292 $88 $33–$190 $160
2024 $544 $94 $34–$206 $164
2025 $261 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $284 15 payments
  2. Corium, Inc. $252 11 payments
  3. GlaxoSmithKline, LLC. $244 14 payments
  4. Ironshore Pharmaceuticals Inc. $215 12 payments
  5. Neos Therapeutics, LP $210 17 payments
  6. Supernus Pharmaceuticals, Inc. $171 5 payments
  7. Sanofi-Aventis U.S. LLC $149 5 payments
  8. Adlon Therapeutics L.P. $147 10 payments
  9. Tris Pharma Inc $143 8 payments
  10. Seqirus USA Inc $106 6 payments
  11. Other $474 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,393 132 payments
Products named General payments · program years 2019–2025
  1. Azstarys $252 11 payments
  2. BEXSERO $200 12 payments
  3. Adzenys XR-ODT $195 16 payments
  4. COTEMPLA XR-ODT $195 16 payments
  5. PREVNAR 20 $167 8 payments
  6. TZIELD $149 5 payments
  7. ADHANSIA XR $147 10 payments
  8. COMIRNATY $141 7 payments
  9. QELBREE $140 4 payments
  10. JORNAY PM $138 8 payments
  11. Other $1,591 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pfizer Inc. $2,500 1 payment

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record